Pediatric Hematology/Oncology

Glomerulonephritis

Questions discussed in this category

For patients with suspected complement-mediated TMA, are there specific clinical or laboratory parameters that can help guide the decision for starting empirical treatment (e.g., eculizumab) while awaiting the results of complement testing?

1 Answer available

Related Topics in Pediatric Hematology/Oncology